Covered recipient · General Payments record
MICHEL APOJ
Allopathic & Osteopathic Physicians Urology
General Payments · PY2022–2024
$2,136.80
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $1,788.99 | 4 |
| Food and Beverage | $311.35 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| INTUITIVE SURGICAL, INC. | $1,500.00 | 1 |
| Astellas Pharma US Inc | $198.99 | 2 |
| Janssen Biotech, Inc. | $90.00 | 1 |
| UROGEN PHARMA, INC. | $62.17 | 2 |
| Ferring Pharmaceuticals Inc. | $55.83 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $47.51 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $32.91 | 1 |
| Teleflex LLC | $31.74 | 2 |
| Endo USA, Inc. | $23.83 | 1 |
| ABBVIE INC. | $20.71 | 1 |
| Verity Pharmaceuticals Inc. | $18.95 | 1 |
| Medtronic, Inc. | $17.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.71 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103233551 | CMS |
| Astellas Pharma US Inc | $99.99 | 09/25/2024 | Education | Undisputed | 01/23/2026 | 1139408501 | CMS |
| Astellas Pharma US Inc | $99.00 | 09/25/2024 | Education | Undisputed | 01/23/2026 | 1139408505 | CMS |
| Boston Scientific Corporation | $47.51 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092288263 | CMS |
| Endo USA, Inc. | $23.83 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138576872 | CMS |
| Ferring Pharmaceuticals Inc. | $28.75 | 10/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137461514 | CMS |
| Ferring Pharmaceuticals Inc. | $27.08 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137461520 | CMS |
| INTUITIVE SURGICAL, INC. | $1,500.00 | 12/11/2024 | Education | Undisputed | 01/23/2026 | 1137133982 | CMS |
| Janssen Biotech, Inc. | $90.00 | 11/05/2024 | Education | Undisputed | 01/23/2026 | 1078467061 | CMS |
| Medtronic, Inc. | $17.70 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119433951 | CMS |
| PROGENICS PHARMACEUTICALS, INC. | $32.91 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128506216 | CMS |
| Teleflex LLC | $16.38 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142088174 | CMS |
| Teleflex LLC | $15.36 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142088176 | CMS |
| UROGEN PHARMA, INC. | $26.92 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137929212 | CMS |
| UROGEN PHARMA, INC. | $35.25 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137931906 | CMS |
| Verity Pharmaceuticals Inc. | $18.95 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080606251 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.